home / openregs / dockets

dockets: FDA-2026-P-12350

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2026-P-12350 FDA Request the FDA determine whether the Reference Listed Drug (RLD) BROMFED-DM (BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE) Oral Syrup, 2 mg/5 mL, 10 mg/5 mL, 30 mg/5 mL; under Abbreviated New Drug Application (ANDA) 088811 held by PHARMOBEDIENT CONSULTING LLC, was voluntarily withdrawn from commercial Nonrulemaking 2026-10-13T19:19:46Z 0b000064b965c4db                     list_pull

Links from other tables

  • 3 rows from docket_id in documents
Powered by Datasette · Queries took 1.867ms · Data license: Public Domain (U.S. Government data) · Data source: U.S. government sources, plus a few identifier registries; each is listed on the methodology page · Privacy